TI

Thomas Ichim

FI Figene: 3 patents #1 of 2Top 50%
TI Therapeutic Solutions International: 3 patents #1 of 7Top 15%
MT Myeloid Therapeutics: 2 patents #1 of 9Top 15%
SP Spinalcyte: 2 patents #1 of 2Top 50%
📍 San Diego, CA: #184 of 4,598 inventorsTop 5%
🗺 California: #1,102 of 67,048 inventorsTop 2%
Overall (2024): #7,296 of 561,600Top 2%
11
Patents 2024

Issued Patents 2024

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12133870 Treatment of opioid addiction using fibroblasts and products thereof Pete O'Heeron 2024-11-05
12090174 Fibroblast therapy for treatment of Duchenne muscular dystrophy Pete O'Heeron 2024-09-17
12011462 Stimulation of mesenchymal stem cell therapeutic activities by T regulatory cells Famela Ramos, James Veltmeyer, Timothy G. Dixon, Feng Lin, Kalina O'Connor 2024-06-18
11976298 Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferase Stephen D. Wolpe, Leonard Miller, Lynnet Koh 2024-05-07
11975030 Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof Pete O'Heeron 2024-05-07
11959102 Augmentation of fibroblast regenerative activity Pete O'Heeron 2024-04-16
11957727 Prevention of neuroinflammation associated memory loss using nutraceutical compositions Famela Ramos, James Veltmeyer, Timothy G. Dixon 2024-04-16
11951146 Stimulation of NK cell activity by using a combination of broccoli, Nigella Sativa, Green Tea, and pterostilbene alone and together with metformin Timothy G. Dixon, Famela Ramos, Wais Kaihani 2024-04-09
11918605 Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancer Samuel C. Wagner, Julia S. Szymanski, Santosh Kesari, Amit Patel, Boris Minev 2024-03-05
11918604 Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancer Samuel C. Wagner, Julia S. Szymanski, Santosh Kesari, Amit Patel, Boris Minev 2024-03-05
11878037 Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis Pete O'Heeron 2024-01-23